Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 24
1991 101
1992 116
1993 137
1994 195
1995 291
1996 395
1997 403
1998 452
1999 450
2000 462
2001 475
2002 472
2003 424
2004 360
2005 449
2006 358
2007 324
2008 310
2009 310
2010 310
2011 289
2012 324
2013 326
2014 339
2015 340
2016 326
2017 286
2018 283
2019 152
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

9,091 results
Results by year
Filters applied: . Clear all
Page 1
Treatment of Helicobacter pylori infection in 2018.
O'Morain NR, et al. Helicobacter 2018 - Review. PMID 30203585
Treatment options for the eradication of Helicobacter pylori continue to evolve. There have been many guidelines for H. pylori treatment published, which may lead to some confusion. ...
Treatment options for the eradication of Helicobacter pylori continue to evolve. There have been many guidelines for H. pylori treatm …
Helicobacter pylori infection: old and new.
Diaconu S, et al. J Med Life 2017 - Review. PMID 28616085 Free PMC article.
The clinical features of Helicobacter pylori range from asymptomatic gastritis to gastrointestinal malignancy. Mucosa-associated lymphoid tissue (MALT) lymphoma is a low-grade B-cell marginal zone lymphoma and Helicobacter pylori has been detected in more than 75% of the patients with MALT lymphoma. ...The eradication of Helicobacter pylori is important in the treatment of the rare condition of the stomach known as MALT lymphoma. ...
The clinical features of Helicobacter pylori range from asymptomatic gastritis to gastrointestinal malignancy. Mucosa-associated lymp …
Current and Future Treatment of Helicobacter pylori Infections.
Matsumoto H, et al. Adv Exp Med Biol 2019 - Review. PMID 31016626 Free PMC article.
Helicobacter pylori is one of the most common human pathogens and it has been estimated that about 50% of the world's population is currently infected. ...
Helicobacter pylori is one of the most common human pathogens and it has been estimated that about 50% of the world's population is c
Clinical differences of Helicobacter pylori infection in children.
Iwańczak BM, et al. Adv Clin Exp Med 2017 - Review. PMID 29211362 Free article.
Helicobacter pylori infection is widely spread all over the world. The prevalence of H. pylori infection in the world varies and depends on numerous factors such as age, ethnicity, geographical and socioeconomic status. ...In the following years, the use of modern molecular techniques has led to the discovery of new Helicobacter strains and their genotypic differentiation. ...
Helicobacter pylori infection is widely spread all over the world. The prevalence of H. pylori infection in the world varies and depe
Acute Neuropsychiatric Symptoms Associated With Antibiotic Treatment of Helicobacter Pylori Infections: A Review.
Neufeld NH, et al. J Psychiatr Pract 2017 - Review. PMID 28072642
Helicobacter pylori infects half the global population. Because serious complications can result from this infection, a so-called "triple therapy" is recommended: treatment with a proton-pump inhibitor and clarithromycin, along with amoxicillin or metronidazole. ...
Helicobacter pylori infects half the global population. Because serious complications can result from this infection, a so-called "tr
The fourth Mexican consensus on Helicobacter pylori.
Bosques-Padilla FJ, et al. Rev Gastroenterol Mex 2018. PMID 29941237 Free article.
Important advances have been made since the last Mexican consensus on the diagnosis and treatment of Helicobacter pylori (H. pylori) infection was published in 2007. Therefore, the Asociación Mexicana de Gastroenterología summoned 20 experts to produce "The Fourth Mexican Consensus on Helicobacter pylori". ...
Important advances have been made since the last Mexican consensus on the diagnosis and treatment of Helicobacter pylori (H. pylori) …
Sequential versus concomitant therapy for treatment of Helicobacter pylori infection: an updated systematic review and meta-analysis.
Wang Y, et al. Eur J Clin Pharmacol 2018 - Review. PMID 28990120
BACKGROUND: Sequential and concomitant therapies are two innovative therapies for Helicobacter pylori (H. pylori) eradication. ...
BACKGROUND: Sequential and concomitant therapies are two innovative therapies for Helicobacter pylori (H. pylori) eradication. ...
[Tailored therapy in treatment of Helicobacter pylori infectionbasedon clarithromycinsensitivity].
Fan X, et al. Zhonghua Yi Xue Za Zhi 2019 - Clinical Trial. PMID 31550810 Chinese.
Objective: To compare eradication rates and compliance of patients with Helicobacter pylori(H. pylori)infection based on clarithromycin sensitivity. ...
Objective: To compare eradication rates and compliance of patients with Helicobacter pylori(H. pylori)infection based on clarithromyc …
9,091 results
Jump to page
Feedback